You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

Sleep Apnea: Positive Airway Pressure Therapy Prescribed

Patients who were prescribed positive airway pressure therapy as a proportion of all patients aged 18 years and older with a diagnosis of moderate or severe obstructive sleep apnea

Date Reviewed: April 8, 2013

Measure Info

CMS 278
Measure Type: 
Process
Measure Steward: 
American Academy of Sleep Medicine
Clinical Topic Area: 
Obstructive Sleep Apnea

Care Setting: 
Outpatient
Data Source: 
Claims
Electronic Health Records
Paper Medical Records

The PMC supports this measure because it aligns with the ACP guideline. The ACP Guideline recommends that continuous positive airway pressure should be used as therapy for patients diagnosed with OSA (Grade: strong recommendation, moderate-quality evidence). However, ACP recommendsmandibular advancement devices (MAD) as an alternative therapy to continuous positive airway pressure for patients diagnosed with OSA who prefer MAD or in those with adverse effects associated with CPAP (Grade: weak recommendation, low-quality evidence). While this clinical situation will fall into the measure exclusion criteria, the PMC suggests it would be more clinically useful if this measure included an option for physicians to satisfy the measure if patients use MAD as a second-line therapy.

As part of an ongoing effort to improve user experience, we have made some updates to the Performance Measures section of ACP. Tell us what you think!